Laura Ambra Nicolini on Muck Rack

Laura Ambra Nicolini

As seen in: International Journal of Cardiology, Journal of Infection
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Laura Ambra

Contact Laura Ambra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - study of Infectious Diseases Working Party of EBMT - Journal of Infection

|
By Malgorzata Mikulska, Laura Ambra Nicolini, Gloria Tridello, Nina Knelange
| Journal of Infection Verified
Highlights • The vast majority of HSCT recipients is eligible for HCV DAA-based treatment. • DAAs are safe and effective in HSCT recipients. • DAAs premature discontinuation was rare and not related to side effects. Abstract Objectives : Limited data is available on HCV directly acting agents (DAAs) in haematopoietic stem cell transplant (HSCT) recipients. This study aimed at reporting the characteristics, treatment practices and treatment efficacy in HSCT recipients with chronic HCV.
Open in Who Shared Issue with article?

Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study

|
By Laura Ambra Nicolini, Vincenzo De Marzo, Silvia Dettori, Matteo Vercellino
| International Journal of Cardiology Verified
Highlights • Early infections in transcatheter aortic valve replacement (TAVR) occur in about 10%. • They are mostly caused by Gram negative bacteria. • They mainly consist of pneumonia and bloodstream infections. • They are predicted by baseline high-risk variables and complicated procedural course. • They are independently associated with increased short- and long-term mortality.
Open in Who Shared Issue with article?

Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis

|
By Laura Ambra Nicolini
| JAMA (The Journal of the American Medical Association) Verified
[Skip to Content Landing] Research Letter April 8, 2019 JAMA Neurol. 2019;76(7):866-867. doi:10.1001/jamaneurol.2019.0522 Full Text Ocrelizumab (Ocrevus [Roche-Genentech]), a second-generation humanized anti-CD20 antibody, has been recently approved for multiple sclerosis (MS).
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified